Pilot Trial of the Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this study is to test the safety and effectiveness of Vibrant capsules in spinal cord injury patients with neurogenic bowel.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Individuals aged 18 years and older with chronic spinal cord injury (SCI) of more than one year.
• Stable neurological level and function of SCI for at least six months.
• Consistent bowel program without changes for at least 3 months.
• At least one scheduled bowel movement (BM) every three days.
• Use of digital stimulation, suppositories, enemas, or mini enemas, as part of the scheduled bowel program.
• Use of oral medications as part of the bowel program.
Locations
United States
Texas
TIRR Memorial Hermann
RECRUITING
Houston
Contact Information
Primary
Argyrios Stampas, MD
argyrios.stampas@uth.tmc.edu
7127975938
Backup
Danira Garcia Gutierrez, BS
7137977133
Time Frame
Start Date: 2025-11-01
Estimated Completion Date: 2026-03-01
Participants
Target number of participants: 12
Treatments
Experimental: Vibrant Capsule
Related Therapeutic Areas
Sponsors
Leads: The University of Texas Health Science Center, Houston
Collaborators: Mission Connect